Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

β-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility.

Abbas MA, Taha MO, Zihlif MA, Disi AM.

Eur J Pharmacol. 2013 Feb 28;702(1-3):12-9. doi: 10.1016/j.ejphar.2013.01.011. Epub 2013 Jan 23.

PMID:
23353590
2.

Endostatin inhibits the growth of endometriotic lesions but does not affect fertility.

Becker CM, Sampson DA, Rupnick MA, Rohan RM, Efstathiou JA, Short SM, Taylor GA, Folkman J, D'Amato RJ.

Fertil Steril. 2005 Oct;84 Suppl 2:1144-55.

PMID:
16210006
3.

Thrombospondin-1 mimetic peptide ABT-898 affects neovascularization and survival of human endometriotic lesions in a mouse model.

Nakamura DS, Edwards AK, Virani S, Thomas R, Tayade C.

Am J Pathol. 2012 Aug;181(2):570-82. doi: 10.1016/j.ajpath.2012.05.010. Epub 2012 Jun 19.

PMID:
22727957
4.

Is montelukast effective in regression of endometrial implants in an experimentally induced endometriosis model in rats?

Kiykac Altinbas S, Tapisiz OL, Cavkaytar S, Simsek G, Oguztuzun S, Goktolga U.

Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:7-12. doi: 10.1016/j.ejogrb.2014.10.026. Epub 2014 Oct 30.

PMID:
25462212
5.

Regression of endometrial explants in a rat model of endometriosis treated with melatonin.

Güney M, Oral B, Karahan N, Mungan T.

Fertil Steril. 2008 Apr;89(4):934-42. Epub 2007 Jun 19.

PMID:
17582405
6.

A potential novel treatment strategy: inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model.

Ozcan Cenksoy P, Oktem M, Erdem O, Karakaya C, Cenksoy C, Erdem A, Guner H, Karabacak O.

Gynecol Endocrinol. 2015 Mar;31(3):219-24. doi: 10.3109/09513590.2014.976197. Epub 2014 Nov 6.

PMID:
25373440
7.

Natural therapies assessment for the treatment of endometriosis.

Ricci AG, Olivares CN, Bilotas MA, Bastón JI, Singla JJ, Meresman GF, Barañao RI.

Hum Reprod. 2013 Jan;28(1):178-88. doi: 10.1093/humrep/des369. Epub 2012 Oct 18.

PMID:
23081870
8.

Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis.

Abbas MA, Taha MO, Disi AM, Shomaf M.

Eur J Pharmacol. 2013 Sep 5;715(1-3):72-5. doi: 10.1016/j.ejphar.2013.06.016. Epub 2013 Jun 25.

PMID:
23810684
9.

Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis?

Bayoglu Tekin Y, Guven S, Kirbas A, Kalkan Y, Tumkaya L, Guvendag Guven ES.

Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:1-6. doi: 10.1016/j.ejogrb.2014.10.041. Epub 2014 Nov 11.

PMID:
25462211
10.

Evaluation of the potential therapeutic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of endometriosis.

García-Pascual CM, Martínez J, Calvo P, Ferrero H, Villanueva A, Pozuelo-Rubio M, Soengas M, Tormo D, Simón C, Pellicer A, Gómez R.

Fertil Steril. 2015 Nov;104(5):1310-8. doi: 10.1016/j.fertnstert.2015.07.1147. Epub 2015 Aug 18.

PMID:
26297642
11.

Regression of endometrial implants by resveratrol in an experimentally induced endometriosis model in rats.

Ergenoğlu AM, Yeniel AÖ, Erbaş O, Aktuğ H, Yildirim N, Ulukuş M, Taskiran D.

Reprod Sci. 2013 Oct;20(10):1230-6. doi: 10.1177/1933719113483014. Epub 2013 Mar 27.

PMID:
23536571
12.

Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model.

Vlahos NF, Gregoriou O, Deliveliotou A, Perrea D, Vlachos A, Zhao Y, Lai J, Creatsas G.

Fertil Steril. 2010 Mar 1;93(4):1316-23. doi: 10.1016/j.fertnstert.2008.10.056. Epub 2009 Jan 14.

PMID:
19147132
13.

Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.

Wang CC, Xu H, Man GC, Zhang T, Chu KO, Chu CY, Cheng JT, Li G, He YX, Qin L, Lau TS, Kwong J, Chan TH.

Angiogenesis. 2013 Jan;16(1):59-69. doi: 10.1007/s10456-012-9299-4. Epub 2012 Sep 5.

PMID:
22948799
14.

Animal models for anti-angiogenic therapy in endometriosis.

Edwards AK, Nakamura DS, Virani S, Wessels JM, Tayade C.

J Reprod Immunol. 2013 Mar;97(1):85-94. doi: 10.1016/j.jri.2012.10.012. Review.

PMID:
23432875
15.

Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers.

Novella-Maestre E, Herraiz S, Vila-Vives JM, Carda C, Ruiz-Sauri A, Pellicer A.

Fertil Steril. 2012 Nov;98(5):1209-17. doi: 10.1016/j.fertnstert.2012.07.1103. Epub 2012 Aug 21.

PMID:
22921078
16.

Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.

Ngô C, Nicco C, Leconte M, Chéreau C, Arkwright S, Vacher-Lavenu MC, Weill B, Chapron C, Batteux F.

J Pathol. 2010 Oct;222(2):148-57. doi: 10.1002/path.2756.

PMID:
20821752
17.

Studies on the surgical induction of endometriosis in the rat.

Vernon MW, Wilson EA.

Fertil Steril. 1985 Nov;44(5):684-94.

PMID:
4054348
18.

Endometrial adult/progenitor stem cells: pathogenetic theory and new antiangiogenic approach for endometriosis therapy.

Pittatore G, Moggio A, Benedetto C, Bussolati B, Revelli A.

Reprod Sci. 2014 Mar;21(3):296-304. doi: 10.1177/1933719113503405. Epub 2013 Sep 13. Review.

PMID:
24037753
19.

Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.

Laschke MW, Schwender C, Scheuer C, Vollmar B, Menger MD.

Hum Reprod. 2008 Oct;23(10):2308-18. doi: 10.1093/humrep/den245. Epub 2008 Jul 4.

PMID:
18603648
20.

Compatibility of a novel thrombospondin-1 analog with fertility and pregnancy in a xenograft mouse model of endometriosis.

Nakamura DS, Edwards AK, Ahn SH, Thomas R, Tayade C.

PLoS One. 2015 Mar 26;10(3):e0121545. doi: 10.1371/journal.pone.0121545. eCollection 2015.

Supplemental Content

Support Center